Related Experiment Video
Updated: May 23, 2026
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
Glioblastoma--a moving target
1Uppsala University, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala, Sweden.
Abstract:
The slow development of effective treatment of glioblastoma is contrasted by the rapidly advancing research on the molecular mechanisms underlying the disease. Amplification and overexpression of receptor tyrosine kinases, particularly EGFR and PDGFRA, are complemented by mutations in the PI3K, RB1, and p53 signaling pathways. In addition to finding effective means to target these pathways, we may take advantage of the recent understanding of the hierarchical structure of tumor cell populations, where the progressive expansion of the tumor relies on a minor subpopulation of glioma stem cells, or glioma-initiating cells. Finding ways to reprogram these cells and block their self-renewal is one of the most important topics for future research.
Insights
Glioblastoma research is advancing molecular understanding, focusing on receptor tyrosine kinases and signaling pathways. Targeting glioma stem cells is crucial for future glioblastoma treatment development.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Glioblastoma treatment development lags behind molecular research.
- Key molecular alterations include receptor tyrosine kinase amplification/overexpression (EGFR, PDGFRA) and mutations in PI3K, RB1, and p53 pathways.
Purpose of the Study:
- To highlight the molecular mechanisms driving glioblastoma.
- To emphasize the potential of targeting glioma stem cells for future therapies.
Main Methods:
- Review of current glioblastoma research.
- Analysis of molecular pathways and tumor cell hierarchy.
Main Results:
- Identified critical molecular targets: EGFR, PDGFRA, PI3K, RB1, and p53 pathways.
- Highlighted the role of glioma stem cells in tumor progression and self-renewal.
Conclusions:
- Targeting specific molecular pathways is essential for glioblastoma treatment.
- Reprogramming or blocking self-renewal of glioma stem cells represents a promising future research direction.
